Workflow
EPS guidance
icon
Search documents
Levi’s set to deliver modest earnings beat and steady guidance in Q1 report
Yahoo Finance· 2026-03-27 16:01
Core Viewpoint - Levi Strauss & Co is expected to report a modest earnings beat for Q1 2026, but limited potential for significant market reaction is anticipated [2][3] Financial Performance - Analysts predict a first quarter EPS beat of $0.01 to $0.02, with fiscal 2026 EPS guidance likely reaffirmed at $1.40 to $1.46 per share [5][3] - Second quarter EPS guidance is expected to be in the range of $0.22 to $0.24 [5] Market Trends - Recent data indicates solid consumer trends, with US direct-to-consumer sales growing approximately 2% year-over-year in Q1, reflecting a ~420-basis-point acceleration from the previous quarter [6] - Website traffic increased by 8% in the US and 11% across key European sites, while US Google searches for the brand rose by 13% year-over-year [6] Investor Sentiment - Despite positive operational trends, investor sentiment has softened, with shares down nearly 13% over the past three months, compared to a roughly 5% decline in the S&P 500 [7] - Short interest has climbed to 12.9%, indicating a slightly bearish sentiment among investors [7] Valuation - UBS maintains a Buy rating with a price target of $33, based on approximately 17 times projected fiscal 2028 EPS of $1.95 [8] - The positive outlook is supported by strong brand fundamentals, controlled promotional activity, and peer-aligned valuation metrics [8]
Sally Beauty (SBH) Down 3.7% Since Last Earnings Report: Can It Rebound?
ZACKS· 2026-03-11 16:31
Core Viewpoint - Sally Beauty's recent earnings report shows mixed results, with adjusted earnings per share beating estimates while net sales slightly missed expectations, indicating potential challenges ahead [2][3]. Financial Performance - Adjusted earnings were 48 cents per share, exceeding the Zacks Consensus Estimate of 47 cents, and reflecting a 12% increase from 43 cents in the previous year [3]. - Consolidated net sales reached $943 million, just below the Zacks Consensus Estimate of $944 million, marking a 0.6% increase from $937.9 million year-over-year [3]. - Global e-commerce sales grew by 11% to $111 million, accounting for 11.7% of total net sales [4]. Margin and Cost Analysis - Adjusted gross margin expanded by 50 basis points to 51.3%, while adjusted selling, general and administrative expenses rose to $404 million, an increase of $6 million from the previous year [5]. - Adjusted operating earnings were $80 million, aligning with the higher end of management's guidance, resulting in an adjusted operating margin of 8.5% [5]. Segment Performance - Sally Beauty Supply segment net sales increased by 1.2% year-over-year to $531.6 million, with comparable sales up 0.1% and an operating margin decline of 50 basis points to 14.7% [6]. - Beauty Systems Group segment net sales decreased by 0.2% to $411.6 million, with comparable sales also down 0.2%, but the operating margin improved by 90 basis points to 13.1% [6]. Financial Health - At the end of the fiscal first quarter, the company had cash and cash equivalents of $157.2 million, long-term debt of $842.5 million, and total stockholders' equity of $823.6 million [7]. - Cash flow from operations was $93 million, with free cash flow of $57 million, and the company repaid $20 million of term loan B debt while repurchasing 1.4 million shares for $21 million [7]. Future Guidance - The company raised the lower end of its fiscal 2026 EPS guidance to an adjusted diluted EPS of $2.02-$2.10, up from the previous range of $2.00-$2.10 [9]. - Consolidated net sales for fiscal 2026 are projected to be between $3.71 billion and $3.77 billion, with comparable sales growth expected to be flat to up 1% [8]. - For the second quarter of fiscal 2026, consolidated net sales are guided to be between $895 million and $905 million, with adjusted operating earnings projected at $68-$71 million [10]. Market Sentiment - Recent estimates for the stock have shown a downward trend, with a consensus estimate shift of -9.16% [11]. - Sally Beauty currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [13].
Biogen outlines $15.25-$16.25 EPS guidance for 2026 while advancing growth products and pipeline (NASDAQ:BIIB)
Seeking Alpha· 2026-02-06 19:16
Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]
PVH narrows full-year EPS guidance to $10.85-$11 while advancing brand innovation (NYSE:PVH)
Seeking Alpha· 2025-12-04 16:59
Group 1 - The article does not provide any specific content or key points related to a company or industry [1]
The Cigna Group (CI) Presents at UBS Global Healthcare Conference 2025 Transcript
Seeking Alpha· 2025-11-12 23:11
Core Insights - Cigna Group has demonstrated strong performance in the third quarter and has reaffirmed its full year EPS guidance of at least $29.60, indicating resilience in a challenging environment [2][3] Company Performance - The company is pleased with its performance this year, particularly in the third quarter, showcasing effective execution and future investments [2] - Cigna has made significant investments in the specialty space, which is projected to grow at a rate of 17% to 19% within a large total addressable market (TAM) [3] Strategic Initiatives - Recently, Cigna announced a new transformative rebate-free model, which is expected to enhance its service offerings [4]